Abstract: Provided herein are antibodies that immunospecifically bind to CD123. Also described are related polynucleotides capable of encoding the provided CD123-specific antibodies or antigen-binding fragments, cells expressing the provided antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled antibodies or antigen-binding fragments. In addition, methods of using the provided antibodies are described. For example, the provided antibodies may be used to diagnose, treat, or monitor CD123-expressing cancer progression, regression, or stability; to determine whether or not a patient should be treated for cancer; or to determine whether or not a subject is afflicted with CD123-expressing cancer and thus may be amenable to treatment with a CD123-specific anti-cancer therapeutic, such as the multispecific antibodies against CD123 and CD3 described herein.

Abstract: Embodiments of the present invention relate to a method and an apparatus for establishing an indoor location feature library. A sever selects, by using identification information of first user equipments (UEs) that is included in received first measurement data, multiple pieces of the first measurement data that have identification information of a same first UE; when the first UE is located indoors, obtaining location information of multiple of first access nodes according to feature attribute information of the multiple of the first access nodes; determining, according to the location information of the multiple of the first access nodes and the feature attribute information of the multiple of the first access nodes, indoor location information of the first UE; and establishing an indoor location feature library by using cell identification information and signal power values of multiple cells and indoor location information of the first UE.

Abstract: Provided herein are isolated antibodies that immunospecifically bind to ROR1, bispecific antibodies comprising an antigen-binding site that immunospecifically binds to ROR1 and an antigen-binding site that immunospecifically binds to CD3, and methods of using the same.

Abstract: A method for providing information about a height of a user equipment is disclosed. In an embodiment the method includes receiving, by user equipment, a first height requirement message sent by a network side device, wherein the first height requirement message is used to obtain a height information of a position in which the user equipment is located, listening, by the user equipment, to a broadcast message of an access node, wherein the broadcast message includes a node identifier of the access node and a receive power information of the access node received by the user equipment, and sending, by the user equipment, a response message to the network side device, wherein the response message includes the node identifier of the access node of the user equipment and the receive power information of the user equipment.

Abstract: A method and device and a system are disclosed. The method may include: obtaining, by a measurement device, a first image that is obtained by photographing an antenna at a first position (101); mapping M characteristic points included in the first image into a first three-dimensional spatial coordinate system, to obtain M three-dimensional space points that are in the first three-dimensional spatial coordinate system and that have a mapping relationship with the M characteristic points (102), where a first mapping photographing direction is parallel to a direction of an axis in the first three-dimensional spatial coordinate system, and the first mapping photographing direction is obtained by mapping a photographing direction of photographing the first image into the first three-dimensional spatial coordinate system; and obtaining a downtilt of the antenna according to a first angle and/or obtaining an azimuth of the antenna according to a second angle (103).

Abstract: A method for listen-before-talk (LBT) operation by an eNodeB (eNB) in a wireless communication network. The method comprises triggering an LBT request to transmit, to a user equipment (UE), at least one of an uplink (UL) grant or downlink (DL) data for UL transmission over an licensed assisted access (LAA), determining an adaptive contention window (CW) size comprising a predetermined minimum value and maximum value for transmitting the DL data and UL grant, performing DL data and UL grant LBT operations in accordance with the adaptive CW size, performing a UL grant LBT operation to transmit a UL grant message to the UE, wherein the UL grant LBT comprises a higher priority than the DL data regardless of a level of QoS of the DL data, multiplexing the UL grant with the DL data, and transmitting the multiplexed UL grant with the DL data transmission to the UE.

Abstract: Embodiments of the present invention relate to a method and an apparatus for establishing an indoor location feature library. A sever selects, by using identification information of first user equipments (UEs) that is included in received first measurement data, multiple pieces of the first measurement data that have identification information of a same first UE; when the first UE is located indoors, obtaining location information of multiple of first access nodes according to feature attribute information of the multiple of the first access nodes; determining, according to the location information of the multiple of the first access nodes and the feature attribute information of the multiple of the first access nodes, indoor location information of the first UE; and establishing an indoor location feature library by using cell identification information and signal power values of multiple cells and indoor location information of the first UE.

Abstract: Provided herein are isolated CD3×PSMA-bispecific antigen-binding molecules or bispecific antigen-binding fragment thereof wherein a FN3 domain specifically binds human prostate specific membrane antigen (PSMA) and a second antigen-binding site immunospecifically binds CD3. Also described are fusion proteins and related polynucleotides capable of encoding the provided fusion proteins and, cells expressing the provided fusion proteins. In addition, methods of using the provided isolated CD3×PSMA-bispecific antigen-binding molecules or bispecific antigen-binding fragment thereof are described.

Abstract: Provided herein are antibodies that immunospecifically bind to CD123. Also described are related polynucleotides capable of encoding the provided CD123-specific antibodies or antigen-binding fragments, cells expressing the provided antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled antibodies or antigen-binding fragments. In addition, methods of using the provided antibodies are described. For example, the provided antibodies may be used to diagnose, treat, or monitor CD123-expressing cancer progression, regression, or stability; to determine whether or not a patient should be treated for cancer; or to determine whether or not a subject is afflicted with CD123-expressing cancer and thus may be amenable to treatment with a CD123-specific anti-cancer therapeutic, such as the multispecific antibodies against CD123 and CD3 described herein.

Abstract: The present invention discloses a method, an apparatus, and a system for collecting information about a WLAN AP. The method specifically includes: a user equipment receives WLAN AP request information from a base station in a Minimization of Drive Tests measurement configuration process, collects WLAN AP information according to the WLAN AP request information, and sends the WLAN AP information to the base station, wherein the WLAN AP request information is used to request the UE to report WLAN AP information. In the technical solutions provided in the embodiments of the present invention, by using an MDT measurement configuration process, a UE may collect and report WLAN AP information based on architecture of a mobile communications network. In this way, WLAN AP information can be conveniently collected.